AIM ImmunoTech Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$130.23 | $130.51 | 9.81% | 11 | $329.85B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£123.32 | £165.99 | 31.97% | 16 | £191.17B |
| NOVN | Novartis | Hold |
10
|
CHF90.54 | CHF105.00 | 18.86% | 9 | CHF184.74B |
| PFE | Pfizer | Outperform |
2
|
$28.18 | $32.87 | 8.23% | 6 | $159.68B |
| GSK | GSK | Outperform |
12
|
£17.81 | £17.30 | 9.49% | 12 | £72.61B |
| BAX | Baxter International Inc | Outperform |
17
|
$35.95 | $44.86 | 22.39% | 5 | $18.32B |
| SRPT | Sarepta Therapeutics | Outperform |
6
|
$132.30 | $158.66 | 25.09% | 6 | $12.51B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$31.02 | $44.75 | 28.95% | 0 | $4.23B |
| MDG1 | Medigene | Buy |
6
|
1.44€ | 2.68€ | 86.11% | 0 | 37.83€M |